Newcastle University Centre for Cancer
@nucancer.bsky.social
NUCancer opened in 2019 to bring together >100 cancer and cancer-related researchers from across the three faculties of Newcastle University. We are focused on world leading cancer discovery research and its translation to new oncology therapeutics.
Reposted by Newcastle University Centre for Cancer
Funded PhD opportunity for anyone interested in using cutting-edge chemistry to look at glycan profiles in prostate cancer samples 🙌🏻
The successful student will be based at the University of York with Prof Alison Parkin with the opportunity to carry out a placement at the @nucancer.bsky.social
The successful student will be based at the University of York with Prof Alison Parkin with the opportunity to carry out a placement at the @nucancer.bsky.social
MRC DiMeN Doctoral Training Partnership: Rapid and sensitive diagnostic ‘fingerprinting’ of prostate cancer O-glycans using Fourier-Transform alternative current voltammetry (FTACV) at University of Y...
PhD Project - MRC DiMeN Doctoral Training Partnership: Rapid and sensitive diagnostic ‘fingerprinting’ of prostate cancer O-glycans using Fourier-Transform alternative current voltammetry ...
eur03.safelinks.protection.outlook.com
November 11, 2025 at 3:48 PM
Funded PhD opportunity for anyone interested in using cutting-edge chemistry to look at glycan profiles in prostate cancer samples 🙌🏻
The successful student will be based at the University of York with Prof Alison Parkin with the opportunity to carry out a placement at the @nucancer.bsky.social
The successful student will be based at the University of York with Prof Alison Parkin with the opportunity to carry out a placement at the @nucancer.bsky.social
Today’s seminar: the “diabolical duo” in liver cancer; neutrophils + platelets!🩸
Targeting their crosstalk could re-wire the tumour microenvironment + make HCC more responsive to immunotherapy.
🗣️Prof. Derek Mann / Erik Ramon Gil (PhD student)
#LiverCancer #Immunotherapy #Cancer #Research
Targeting their crosstalk could re-wire the tumour microenvironment + make HCC more responsive to immunotherapy.
🗣️Prof. Derek Mann / Erik Ramon Gil (PhD student)
#LiverCancer #Immunotherapy #Cancer #Research
November 10, 2025 at 4:39 PM
Today’s seminar: the “diabolical duo” in liver cancer; neutrophils + platelets!🩸
Targeting their crosstalk could re-wire the tumour microenvironment + make HCC more responsive to immunotherapy.
🗣️Prof. Derek Mann / Erik Ramon Gil (PhD student)
#LiverCancer #Immunotherapy #Cancer #Research
Targeting their crosstalk could re-wire the tumour microenvironment + make HCC more responsive to immunotherapy.
🗣️Prof. Derek Mann / Erik Ramon Gil (PhD student)
#LiverCancer #Immunotherapy #Cancer #Research
Fantastic news 🎉
Dr Frederik van Delft & Dr Alistair Poll have been awarded a £353k Children with Cancer UK Research Project Grant (2026–29) to tackle drug-resistant T-cell Acute Lymphoblastic Leukaemia in children. (1/2)
#ChildhoodCancer #TALL #CancerResearch
Dr Frederik van Delft & Dr Alistair Poll have been awarded a £353k Children with Cancer UK Research Project Grant (2026–29) to tackle drug-resistant T-cell Acute Lymphoblastic Leukaemia in children. (1/2)
#ChildhoodCancer #TALL #CancerResearch
November 7, 2025 at 4:15 PM
Fantastic news 🎉
Dr Frederik van Delft & Dr Alistair Poll have been awarded a £353k Children with Cancer UK Research Project Grant (2026–29) to tackle drug-resistant T-cell Acute Lymphoblastic Leukaemia in children. (1/2)
#ChildhoodCancer #TALL #CancerResearch
Dr Frederik van Delft & Dr Alistair Poll have been awarded a £353k Children with Cancer UK Research Project Grant (2026–29) to tackle drug-resistant T-cell Acute Lymphoblastic Leukaemia in children. (1/2)
#ChildhoodCancer #TALL #CancerResearch
The Wolfson Childhood Cancer Research Centre at the Herschel Building has earned the Silver LEAF Award for sustainable lab practices! 🥈
Reducing waste, saving energy & going greener every day. 💚
#Sustainability #GreenLabs #LEAFAward #ScienceForGood #NetZero #EcoInnovation
Reducing waste, saving energy & going greener every day. 💚
#Sustainability #GreenLabs #LEAFAward #ScienceForGood #NetZero #EcoInnovation
October 21, 2025 at 3:51 PM
The Wolfson Childhood Cancer Research Centre at the Herschel Building has earned the Silver LEAF Award for sustainable lab practices! 🥈
Reducing waste, saving energy & going greener every day. 💚
#Sustainability #GreenLabs #LEAFAward #ScienceForGood #NetZero #EcoInnovation
Reducing waste, saving energy & going greener every day. 💚
#Sustainability #GreenLabs #LEAFAward #ScienceForGood #NetZero #EcoInnovation
🎓 Great turnout for the first #NUCancer seminar!
Thank you to everyone who joined Prof Christina Halsey for an inspiring talk on improving CNS leukaemia treatmentand reducing neurotoxicity in children.
🧠 Smarter, safer therapies ahead.
#CancerResearch #Leukaemia #Oncology
Thank you to everyone who joined Prof Christina Halsey for an inspiring talk on improving CNS leukaemia treatmentand reducing neurotoxicity in children.
🧠 Smarter, safer therapies ahead.
#CancerResearch #Leukaemia #Oncology
October 14, 2025 at 12:59 PM
🎓 Great turnout for the first #NUCancer seminar!
Thank you to everyone who joined Prof Christina Halsey for an inspiring talk on improving CNS leukaemia treatmentand reducing neurotoxicity in children.
🧠 Smarter, safer therapies ahead.
#CancerResearch #Leukaemia #Oncology
Thank you to everyone who joined Prof Christina Halsey for an inspiring talk on improving CNS leukaemia treatmentand reducing neurotoxicity in children.
🧠 Smarter, safer therapies ahead.
#CancerResearch #Leukaemia #Oncology
🏆 Huge congratulations to Professor Sir John Burn and his team!
They’ve won the CRUK Research Horizons “Translational Project of the Year” Award, recognising their efforts toward turning cancer research into real-world patient impact. 💙
#CancerResearch #InnovationInOncology
They’ve won the CRUK Research Horizons “Translational Project of the Year” Award, recognising their efforts toward turning cancer research into real-world patient impact. 💙
#CancerResearch #InnovationInOncology
October 10, 2025 at 9:33 AM
🏆 Huge congratulations to Professor Sir John Burn and his team!
They’ve won the CRUK Research Horizons “Translational Project of the Year” Award, recognising their efforts toward turning cancer research into real-world patient impact. 💙
#CancerResearch #InnovationInOncology
They’ve won the CRUK Research Horizons “Translational Project of the Year” Award, recognising their efforts toward turning cancer research into real-world patient impact. 💙
#CancerResearch #InnovationInOncology
💙 1 in 8 UK men will develop prostate cancer — but the risk is twice as high for men of African ancestry.
Yet, research in this group is still limited. That needs to change.
#MensHealth #ProstateCancer
Yet, research in this group is still limited. That needs to change.
#MensHealth #ProstateCancer
September 30, 2025 at 1:46 PM
💙 1 in 8 UK men will develop prostate cancer — but the risk is twice as high for men of African ancestry.
Yet, research in this group is still limited. That needs to change.
#MensHealth #ProstateCancer
Yet, research in this group is still limited. That needs to change.
#MensHealth #ProstateCancer
Reposted by Newcastle University Centre for Cancer
Last week on #WorldCancerResearchDay the whole lab and other colleagues from @nucancer.bsky.social turned into bakers to help fundraising for @cancerresearchuk.org, a charity close to us for their commitment to fund groundbreaking projects in cancer research. Lovely seeing the public engaged!
September 28, 2025 at 1:20 PM
Last week on #WorldCancerResearchDay the whole lab and other colleagues from @nucancer.bsky.social turned into bakers to help fundraising for @cancerresearchuk.org, a charity close to us for their commitment to fund groundbreaking projects in cancer research. Lovely seeing the public engaged!
Reposted by Newcastle University Centre for Cancer
Research is not a solo effort.
It takes teamwork. It takes belief. It takes collaboration.
We know what it takes to beat blood cancer and so does @dr-ahlamq.bsky.social whose work is funded by @bloodcanceruk.bsky.social grant co-led by Lisa & @letimarchetti.bsky.social
#BloodCancerAwarenessMonth
It takes teamwork. It takes belief. It takes collaboration.
We know what it takes to beat blood cancer and so does @dr-ahlamq.bsky.social whose work is funded by @bloodcanceruk.bsky.social grant co-led by Lisa & @letimarchetti.bsky.social
#BloodCancerAwarenessMonth
September 4, 2025 at 8:23 AM
Research is not a solo effort.
It takes teamwork. It takes belief. It takes collaboration.
We know what it takes to beat blood cancer and so does @dr-ahlamq.bsky.social whose work is funded by @bloodcanceruk.bsky.social grant co-led by Lisa & @letimarchetti.bsky.social
#BloodCancerAwarenessMonth
It takes teamwork. It takes belief. It takes collaboration.
We know what it takes to beat blood cancer and so does @dr-ahlamq.bsky.social whose work is funded by @bloodcanceruk.bsky.social grant co-led by Lisa & @letimarchetti.bsky.social
#BloodCancerAwarenessMonth
🚨New work from the #NUCancer Paediatric Brain Tumour Group shows not all MYC/MYCN-amplified medulloblastomas are the same.
🔹 Some patients face near-incurable disease & need new therapies
🔹 Others can survive long-term with current treatment
#ChildhoodCancer #Medulloblastoma
🔹 Some patients face near-incurable disease & need new therapies
🔹 Others can survive long-term with current treatment
#ChildhoodCancer #Medulloblastoma
September 3, 2025 at 11:04 AM
🚨New work from the #NUCancer Paediatric Brain Tumour Group shows not all MYC/MYCN-amplified medulloblastomas are the same.
🔹 Some patients face near-incurable disease & need new therapies
🔹 Others can survive long-term with current treatment
#ChildhoodCancer #Medulloblastoma
🔹 Some patients face near-incurable disease & need new therapies
🔹 Others can survive long-term with current treatment
#ChildhoodCancer #Medulloblastoma
Reposted by Newcastle University Centre for Cancer
🧬 Engineered nanobodies binding and stabilizing cancer-mutant p16INK4a—without blocking its CDK6 interaction or cell-cycle arrest function, in press at Structure from Endicott @nucancer.bsky.social and @lauraitzhaki.bsky.social groups!
📖 www.cell.com/structure/fu...
📖 www.cell.com/structure/fu...
Nanobodies restore stability to cancer-associated mutants of tumor suppressor protein p16INK4a
Burbidge et al. characterize nanobodies against the tumor suppressor and CDK4/6 inhibitor
p16INK4a in vitro and in cells. They show the nanobodies restore mutant p16INK4a stability.
Nanobody binding t...
www.cell.com
August 15, 2025 at 7:43 AM
🧬 Engineered nanobodies binding and stabilizing cancer-mutant p16INK4a—without blocking its CDK6 interaction or cell-cycle arrest function, in press at Structure from Endicott @nucancer.bsky.social and @lauraitzhaki.bsky.social groups!
📖 www.cell.com/structure/fu...
📖 www.cell.com/structure/fu...
Celebrating Excellence: NU Cancer Conference 2025 Prize winner spotlight 🏆
Congrats to Dr. Eleanor Hackney on winning a poster award! Eleanor shined a light on her research around the utility of multiple FIT testing in symptomatic colorectal cancer patients. 🧪
#CancerResearch
Congrats to Dr. Eleanor Hackney on winning a poster award! Eleanor shined a light on her research around the utility of multiple FIT testing in symptomatic colorectal cancer patients. 🧪
#CancerResearch
August 12, 2025 at 10:42 AM
Celebrating Excellence: NU Cancer Conference 2025 Prize winner spotlight 🏆
Congrats to Dr. Eleanor Hackney on winning a poster award! Eleanor shined a light on her research around the utility of multiple FIT testing in symptomatic colorectal cancer patients. 🧪
#CancerResearch
Congrats to Dr. Eleanor Hackney on winning a poster award! Eleanor shined a light on her research around the utility of multiple FIT testing in symptomatic colorectal cancer patients. 🧪
#CancerResearch
🎉 Huge congratulations to Prof. Linda Sharp, Dr. Laura Woods & Dr. Christina Dobson on receiving a £40,000 grant from @HDR_UK North for their 9-month project: “Epidemiology of Early Onset Colorectal Cancer in England” 👏
#ColorectalCancer #EarlyDiagnosis #PublicHealth
#ColorectalCancer #EarlyDiagnosis #PublicHealth
August 7, 2025 at 9:48 AM
🎉 Huge congratulations to Prof. Linda Sharp, Dr. Laura Woods & Dr. Christina Dobson on receiving a £40,000 grant from @HDR_UK North for their 9-month project: “Epidemiology of Early Onset Colorectal Cancer in England” 👏
#ColorectalCancer #EarlyDiagnosis #PublicHealth
#ColorectalCancer #EarlyDiagnosis #PublicHealth
🚨 New publication
Prof. Mike Waring & team have advanced micelle-promoted DNA-encoded library synthesis through surfactant optimisation.
Published in @orgbiomolchem.rsc.org.
🔬 Read more: pubs.rsc.org/.../ArticleL...
#CancerResearch #MedicinalChemistry #DrugDiscovery
Prof. Mike Waring & team have advanced micelle-promoted DNA-encoded library synthesis through surfactant optimisation.
Published in @orgbiomolchem.rsc.org.
🔬 Read more: pubs.rsc.org/.../ArticleL...
#CancerResearch #MedicinalChemistry #DrugDiscovery
August 1, 2025 at 12:47 PM
🚨 New publication
Prof. Mike Waring & team have advanced micelle-promoted DNA-encoded library synthesis through surfactant optimisation.
Published in @orgbiomolchem.rsc.org.
🔬 Read more: pubs.rsc.org/.../ArticleL...
#CancerResearch #MedicinalChemistry #DrugDiscovery
Prof. Mike Waring & team have advanced micelle-promoted DNA-encoded library synthesis through surfactant optimisation.
Published in @orgbiomolchem.rsc.org.
🔬 Read more: pubs.rsc.org/.../ArticleL...
#CancerResearch #MedicinalChemistry #DrugDiscovery
Reposted by Newcastle University Centre for Cancer
Congratulations to two of our scientists, professors Ruth Plummer and Stephen O’Brien, who have been appointed as national cancer drug experts by @england.nhs.uk, leading in ensuring patients have the best possible access to new cancer treatments.
#WeAreNCL
#WeAreNCL
July 31, 2025 at 7:22 AM
Congratulations to two of our scientists, professors Ruth Plummer and Stephen O’Brien, who have been appointed as national cancer drug experts by @england.nhs.uk, leading in ensuring patients have the best possible access to new cancer treatments.
#WeAreNCL
#WeAreNCL
🏆 NU Cancer Conference 2025: Prize Winner Spotlight
PhD student Eleanor Woodward won a Flash Talk Award for her work on characterising structural variants in tumour samples using long-read sequencing via
@oxfordnanopore.bsky.social platforms. 🧬
#CancerResearch #PhDLife #WomenInSTEM
PhD student Eleanor Woodward won a Flash Talk Award for her work on characterising structural variants in tumour samples using long-read sequencing via
@oxfordnanopore.bsky.social platforms. 🧬
#CancerResearch #PhDLife #WomenInSTEM
July 30, 2025 at 2:32 PM
🏆 NU Cancer Conference 2025: Prize Winner Spotlight
PhD student Eleanor Woodward won a Flash Talk Award for her work on characterising structural variants in tumour samples using long-read sequencing via
@oxfordnanopore.bsky.social platforms. 🧬
#CancerResearch #PhDLife #WomenInSTEM
PhD student Eleanor Woodward won a Flash Talk Award for her work on characterising structural variants in tumour samples using long-read sequencing via
@oxfordnanopore.bsky.social platforms. 🧬
#CancerResearch #PhDLife #WomenInSTEM
🏆 #NUCancer Conference 2025: Prize Winner Spotlight
Congratulations to Louisa Taylor, PhD, winner of a Flash Talk Award for her cutting-edge work on high-risk MYC-amplified #medulloblastoma. 🔬💡
#childhoodcancer #childhoodcancerawareness #pediatriccancer #cancerresearch
Congratulations to Louisa Taylor, PhD, winner of a Flash Talk Award for her cutting-edge work on high-risk MYC-amplified #medulloblastoma. 🔬💡
#childhoodcancer #childhoodcancerawareness #pediatriccancer #cancerresearch
July 24, 2025 at 7:38 AM
🏆 #NUCancer Conference 2025: Prize Winner Spotlight
Congratulations to Louisa Taylor, PhD, winner of a Flash Talk Award for her cutting-edge work on high-risk MYC-amplified #medulloblastoma. 🔬💡
#childhoodcancer #childhoodcancerawareness #pediatriccancer #cancerresearch
Congratulations to Louisa Taylor, PhD, winner of a Flash Talk Award for her cutting-edge work on high-risk MYC-amplified #medulloblastoma. 🔬💡
#childhoodcancer #childhoodcancerawareness #pediatriccancer #cancerresearch
🎉Congratulations to Dr. Shelby Barnett on receiving the joint EPHAR-EACPT Young Investigator Award in translational Pharmacology.
Great work Shelby! 👏
#NUcancer
Great work Shelby! 👏
#NUcancer
July 17, 2025 at 8:10 AM
🎉Congratulations to Dr. Shelby Barnett on receiving the joint EPHAR-EACPT Young Investigator Award in translational Pharmacology.
Great work Shelby! 👏
#NUcancer
Great work Shelby! 👏
#NUcancer
We're delighted to share that @newcastleuni.bsky.social has officially approved renewal of the #NUCancerCentre for 2025-30.
We look forward to continuing this important journey together over the next five years.
We look forward to continuing this important journey together over the next five years.
July 15, 2025 at 12:55 PM
We're delighted to share that @newcastleuni.bsky.social has officially approved renewal of the #NUCancerCentre for 2025-30.
We look forward to continuing this important journey together over the next five years.
We look forward to continuing this important journey together over the next five years.
The NU Conference was a big success with a superb plenary from Ram DasGupta (CRUK Scotland). Prizes for talks - J Dishington (1st) and H Stewart; flash talks - E Woodward (1st), L Taylor (2nd); posters - E Hackney (1st), K Papa (2nd). Congrats and to all presenters for giving us a memorable day!
June 16, 2025 at 2:26 PM
The NU Conference was a big success with a superb plenary from Ram DasGupta (CRUK Scotland). Prizes for talks - J Dishington (1st) and H Stewart; flash talks - E Woodward (1st), L Taylor (2nd); posters - E Hackney (1st), K Papa (2nd). Congrats and to all presenters for giving us a memorable day!
Reposted by Newcastle University Centre for Cancer
Dr Amy Collins is busy at her poster on modelling hepatocellular carcinoma at the 2025 EASL Liver Cancer Summit in Paris. Funding for her work from Cancer Research U.K.
February 20, 2025 at 12:28 PM
Dr Amy Collins is busy at her poster on modelling hepatocellular carcinoma at the 2025 EASL Liver Cancer Summit in Paris. Funding for her work from Cancer Research U.K.
An important new study on the genetics of liver cancer published today in Nature led by Prof Tom Bird of Edinburgh University with contributions from @damann1.bsky.social, @jleslie1.bsky.social and others of @nucancer.bsky.social.
Human-correlated genetic models identify precision therapy for liver cancer - Nature
As proof of principle, an analysis using a suite of human-aligned immunocompetent mouse models of hepatocellular carcinoma identifies a promising therapeutic candidate, cladribine, which acts in ...
www.nature.com
February 19, 2025 at 7:18 PM
An important new study on the genetics of liver cancer published today in Nature led by Prof Tom Bird of Edinburgh University with contributions from @damann1.bsky.social, @jleslie1.bsky.social and others of @nucancer.bsky.social.
It was a pleasure hosting @walkolab.bsky.social from the Bart's Centre for Squamous Cancer in our NUCoRE Cancer seminar series this week where he told us about his exciting research on transcriptional addiction.
February 19, 2025 at 10:43 AM
It was a pleasure hosting @walkolab.bsky.social from the Bart's Centre for Squamous Cancer in our NUCoRE Cancer seminar series this week where he told us about his exciting research on transcriptional addiction.
Our talented PhD student Keara wins a regional prize for her work on developing a 96-well scale model of liver cancer tumour microenvironment. Congratulations Keara!
February 11, 2025 at 11:36 PM
Our talented PhD student Keara wins a regional prize for her work on developing a 96-well scale model of liver cancer tumour microenvironment. Congratulations Keara!